BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30121449)

  • 1. The lack of meaningful association between depression severity measures and neurocognitive performance.
    Keilp JG; Madden SP; Gorlyn M; Burke AK; Oquendo MA; Mann JJ
    J Affect Disord; 2018 Dec; 241():164-172. PubMed ID: 30121449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder.
    Lam RW; Iverson GL; Evans VC; Yatham LN; Stewart K; Tam EM; Axler A; Woo C
    J Affect Disord; 2016 Oct; 203():55-61. PubMed ID: 27280963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints.
    Mohn C; Rund BR
    BMC Psychiatry; 2016 Apr; 16():108. PubMed ID: 27095362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.
    Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS
    J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive subgroups in major depressive disorder.
    Martin DM; Wollny-Huttarsch D; Nikolin S; McClintock SM; Alonzo A; Lisanby SH; Loo CK
    Neuropsychology; 2020 Sep; 34(6):726-734. PubMed ID: 32324004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinically useful self-report measure of the DSM-5 mixed features specifier of major depressive disorder.
    Zimmerman M; Chelminski I; Young D; Dalrymple K; Martinez JH
    J Affect Disord; 2014 Oct; 168():357-62. PubMed ID: 25103631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cognitive performance in bipolar disorder, major depressive disorder, unaffected first-degree relatives, and healthy controls.
    Bo Q; Dong F; Li X; Li F; Li P; Yu H; He F; Zhang G; Wang Z; Ma X; Wang C
    Psychiatry Clin Neurosci; 2019 Feb; 73(2):70-76. PubMed ID: 30393945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appetite loss and neurocognitive deficits in late-life depression.
    Potter GG; McQuoid DR; Steffens DC
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):647-54. PubMed ID: 25315155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anhedonia and cognitive function in adults with MDD: results from the International Mood Disorders Collaborative Project.
    McIntyre RS; Woldeyohannes HO; Soczynska JK; Maruschak NA; Wium-Andersen IK; Vinberg M; Cha DS; Lee Y; Xiao HX; Gallaugher LA; Dale RM; Alsuwaidan MT; Mansur RB; Muzina DJ; Carvalho AF; Jerrell JM; Kennedy SH
    CNS Spectr; 2016 Oct; 21(5):362-366. PubMed ID: 26714651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between cognitive deficits and suicidal ideation in patients with major depressive disorder.
    Pu S; Setoyama S; Noda T
    Sci Rep; 2017 Sep; 7(1):11637. PubMed ID: 28912439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the best screening test for depression in chronic spinal pain patients?
    Choi Y; Mayer TG; Williams MJ; Gatchel RJ
    Spine J; 2014 Jul; 14(7):1175-82. PubMed ID: 24225008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of neurocognitive impairment at 2years after a first-episode major depressive disorder.
    Gu CZ; He HL; Duan HF; Su ZH; Chen H; Gan JL
    Compr Psychiatry; 2016 Jul; 68():24-33. PubMed ID: 27234179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative symptoms in patients with major depressive disorder: a preliminary report.
    Galynker II; Cohen LJ; Cai J
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jul; 13(3):171-6. PubMed ID: 10910087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gender differences in the neurocognitive components of depression].
    Sárosi A; Gonda X; Balogh G; Székely A; Sasvári M; Faludi G
    Neuropsychopharmacol Hung; 2008 Oct; 10(4):191-9. PubMed ID: 19213198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and emotional biomarkers of melancholic depression: An iSPOT-D report.
    Day CV; Gatt JM; Etkin A; DeBattista C; Schatzberg AF; Williams LM
    J Affect Disord; 2015 May; 176():141-50. PubMed ID: 25710095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision-making of patients with major depressive disorder in the framework of action control.
    Rinaldi R; Lefebvre L; Joachim A; Rossignol M
    Cogn Neuropsychiatry; 2020 Jan; 25(1):71-83. PubMed ID: 31672088
    [No Abstract]   [Full Text] [Related]  

  • 17. Discrepancy between self- and observer-rated depression severities as a predictor of vulnerability to suicide in patients with mild depression.
    Tsujii N; Akashi H; Mikawa W; Tsujimoto E; Niwa A; Adachi T; Shirakawa O
    J Affect Disord; 2014 Jun; 161():144-9. PubMed ID: 24751322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults.
    Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M
    J Neurovirol; 2016 Feb; 22(1):56-65. PubMed ID: 26304840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eveningness is associated with greater subjective cognitive impairment in individuals with self-reported symptoms of unipolar depression.
    Coleman MY; Cain SW
    J Affect Disord; 2019 Sep; 256():404-415. PubMed ID: 31228792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
    Torrent C; Martinez-Arán A; Daban C; Amann B; Balanzá-Martínez V; del Mar Bonnín C; Cruz N; Franco C; Tabarés-Seisdedos R; Vieta E
    Compr Psychiatry; 2011; 52(6):613-22. PubMed ID: 21295774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.